CAR T-Cell Therapy - Patient Education

Car T-Cell Therapy
PATIENT EDUCATION

  • Home
  • Preparing for CAR T-Cell Therapy
    • Your Care Team
    • Evaluation Tests and Screening
    • Financial and Insurance Planning
    • Identifying a Caregiver
    • Short-Term Accommodations
    • Psychosocial Support
  • Steps of CAR T-cell Therapy
    • Step 1: Cell Collection
    • Step 2: CAR T-Cell Manufacturing
    • Step 3: Bridging Therapy
    • Step 4: Preparative Chemotherapy
    • Step 5: CAR T-Cell Infusion
  • Side Effects
  • Receiving CAR T-Cell Therapy in the Hospital
  • Receiving CAR T-Cell Therapy in the Outpatient Clinic
  • Recovering from CAR T-Cell Therapy
    • Infection Precautions
    • Nutrition
    • Physical Activity
  • When to Call Your Care Team
  • For Caregivers
  • Resources
  • Contact Information

Step 1: Cell Collection 

The first step is to collect your T cells. This process – called leukapheresis – takes place several weeks before you begin your preparative chemotherapy, which occurs shortly before your CAR T-cell infusion. During leukapheresis, some of your blood is removed from your body through a needle in one arm, moved through a cell separator to collect needed blood cell components, and then returned through a needle in your other arm.

Some patients may require a central line to be placed for the apheresis process. If this is needed, you will be scheduled for this line to be placed with Interventional Radiology at Brigham and Women’s Hospital the day before or the day of your collection, and removed by Interventional Radiology after your collection is complete. Your line will be placed again before your CAR T-cell infusion.

The leukapheresis procedure usually takes 4 hours and is completed in one day. It takes place at the Kraft Family Blood Donor Center at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, located in Dana-Farber’s Jimmy Fund Building (35 Binney St., Boston).

​Step 2: CAR T-Cell Manufacturing 
          Home | Evaluation & Treatment | Side Effects | Recovery after Discharge | For Caregivers | Resources | Important Contact Information | For Clinicians
© 2018 CAR T-Cell Therapy at Dana-Farber Cancer Institute